首页> 外文期刊>Integrative Biology: quantitative biosciences from nano to macro >Drug repositioning through incomplete bi-cliques in an integrated drug-target-disease network
【24h】

Drug repositioning through incomplete bi-cliques in an integrated drug-target-disease network

机译:通过整合的药物靶标疾病网络中不完整的双位点进行药物重新定位

获取原文
获取原文并翻译 | 示例
           

摘要

Recently, there has been much interest in gene-disease networks and polypharmacology as a basis for drug repositioning. Here, we integrate data from structural and chemical databases to create a drug-target-disease network for 147 promiscuous drugs, their 553 protein targets, and 44 disease indications. Visualizing and analyzing such complex networks is still an open problem. We approach it by mining the network for network motifs of bi-cliques. In our case, a bi-clique is a subnetwork in which every drug is linked to every target and disease. Since the data are incomplete, we identify incomplete bi-cliques, whose completion introduces novel, predicted links from drugs to targets and diseases. We demonstrate the power of this approach by repositioning cardiovascular drugs to parasitic diseases, by predicting the cancer-related kinase PIK3CG as a novel target of resveratrol, and by identifying for five drugs a shared binding site in four serine proteases and novel links to cancer, cardiovascular, and parasitic diseases.
机译:最近,人们对基因疾病网络和多药理学作为药物重新定位的基础非常感兴趣。在这里,我们整合了来自结构和化学数据库的数据,以创建针对147种混杂药物,其553种蛋白质靶标和44种疾病适应症的药物靶标疾病网络。可视化和分析这种复杂的网络仍然是一个未解决的问题。我们通过挖掘网络以获取双斜体的网络图案来实现这一目标。在我们的案例中,双室是一个子网,其中每种药物都与每种靶标和疾病相关联。由于数据不完整,因此我们确定了不完整的双室,其完成引入了从药物到靶标和疾病的新颖,预测的联系。我们通过将心血管药物重新定位于寄生虫疾病,预测与癌症有关的激酶PIK3CG作为白藜芦醇的新型靶标,并为五种药物确定四种丝氨酸蛋白酶中的共享结合位点以及与癌症的新型联系,来证明这种方法的功效,心血管和寄生虫病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号